Recombinant TNFSF4 (Oxelumab Biosimilar) antibody

Catalog No. ABIN7581739

The Human Monoclonal anti-TNFSF4 (Oxelumab Biosimilar) antibody has been validated for FACS, Func, BLI, ELISA and SPR. It is suitable to detect TNFSF4 (Oxelumab Biosimilar) in samples from Human.

Quick Overview for Recombinant TNFSF4 (Oxelumab Biosimilar) antibody (ABIN7581739)

Target: TNFSF4 (Oxelumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This TNFSF4 (Oxelumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), Functional Studies (Func), Bio-Layer Interferometry (BLI), ELISA, Surface Plasmon Resonance (SPR)

Product Details anti-TNFSF4 (Oxelumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-TNFSF4 / OX40L / CD252 Reference Antibody (oxelumab)

Sequence: EVQLLESGGG LVQPGGSLRL SCAASGFTFN SYAMSWVRQA PGKGLEWVSI ISGSGGFTYY ADSVKGRFTI SRDNSRTTLY LQMNSLRAED TAVYYCAKDR LVAPGTFDYW GQGALVTVSS ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKKVEP KSCDKTHTCP PCPAPELLGG PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSRDE LTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW QQGNVFSCSV MHEALHNHYT QKSLSLSPG,DIQMTQSPSS LSASVGDRVT ITCRASQGIS SWLAWYQQKP EKAPKSLIYA ASSLQSGVPS RFSGSGSGTD FTLTISSLQP EDFATYYCQQ YNSYPYTFGQ GTKLEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC

Characteristics: Anti-TNFSF4 / OX40L / CD252 Reference Antibody (oxelumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Comment:

Therapeutic Agents by Target and Mechanism: OX40L inhibitors

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for TNFSF4 (Oxelumab Biosimilar)

Target: TNFSF4 (Oxelumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P23510